|
⚲
|
| Keyboard |
| Deer Management Co LLC
✚
|
|
|---|---|
| CRD # | 159279 |
| SEC # | 801-125875 |
| CIK # | 0001494127 |
| AUM | 20.24 B (2026-05-13) |
| Employees | 191 (43% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 914-833-5300 |
| Address | 1865 Palmer Avenue Larchmont, NY 10538 |
| Source | [IAPD] [EDGAR] [Website] [Twitter] [LinkedIn] [Facebook] [Instagram] |
| Total AUM ($B) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 5. Fees and Compensation Management Fees BVP is generally paid a management fee paid quarterly in advance by each Fund. The fee accrues from a given commencement date in the Fund’s Governing Documents and continues through the final liquidation of the Fund. Management fees are generally payable out of current cash flow, disposition proceeds or from drawdowns from investors. Installments of the management fee payable for any period other than a full quarterly period are prorated for the actual number of days in such period, and in the case of the final quarterly period that the management fee is payable, BVP will refund the amount of the management fee allocable to that portion of such period which is subsequent to the date that management fee is no longer payable. Except for rare circumstances described in the applicable Governing Documents of each Fund, investors are generally not permitted to withdraw or redeem interests in the Funds. Investors in the Funds also bear certain fund expenses as further described below. The management fees are negotiated collectively with the investors of each Fund and are subject to waiver or reduction by BVP. For example, certain of BVP’s principals, personnel, BVP outside advisory personnel, and other individuals associated with BVP typically invest in or alongside the Funds in a separate Fund vehicle. Management fees assessed on such investments may be substantially reduced or as is more typical, waived entirely in the sole discretion of the applicable General Partner or managing member. Vehicles that do not pay management fees will not receive the benefit of any offset. Waived or reduced management fees are also not subject to management fee offsets. Due to waived or reduced management fees by BVP and/or timing of receipt of compensation subject to offsets, it is possible that management fee offsets will be delayed and not be fully realized by investors in the relevant Fund, resulting in a net additional benefit to BVP. The precise amount of, and the manner and calculation of, the management fees for each client is disclosed in the Governing Documents of the Fund and varies from Fund to Fund. Under the Funds’ Governing Documents, the management fee will be calculated and charged on a basis that generally is not tied to the Fund’s then-current net asset value. As further specified in the relevant Governing Documents, management fees will initially generally be charged based on a formula tied to the amount of aggregate subscriptions of the limited partners of a Fund. Upon a date specified in the relevant Governing Documents of the Fund, the rate will be reduced by a given amount until the tenth anniversary of the commencement of the Fund. At that time, the Fund’s management fee generally will be charged and calculated based on a formula tied to the amount of contributed capital or the cost basis of remaining portfolio investments made by the Fund. As a result, except where the Governing Documents expressly provide to the contrary, the amount of management fees generally will not correspond with fluctuations in the Fund’s net asset value, including where the fair market value of an investment exceeds or falls below the total amount of contributed capital or the cost basis relating to such investment. Therefore, the management fee generally will not be reduced in connection with any partial sales or dispositions, distributions, partial realizations, reorganizations, recapitalization (including recapitalizations involving dividends) and write downs except as required by the relevant Governing Documents. The Funds’ Governing Documents set forth the full list of terms under which a Fund’s management fee will be reduced, offset or otherwise be limited, and consequently investors should expect to bear the full specified management fee in the relevant Governing Documents until they are reduced in the circumstances and on the date(s) specified therein. With respect to BVP Forge, as set forth and discussed in more detail in each Fund’s Governing Documents, the management fee is calculated as a percentage of non-affiliated aggregate commitments until the earlier of (i) the date the Investment Period expires and (ii) and Successor Fund Step-Down Date (each, as defined in the BVP Forge Governing Documents) (the “Step-Down Date”). After the Step-Down Date, the fund’s management fee will be reduced to an amount equal to a percentage of the non-affiliated partners’ investment contributions made with respect to investments that have not been disposed of or completely written-off for U.S. federal income tax purposes, in each case as determined on the first day of the period with respect to which a determination is being made; provided that investments (other than bridge financings) in a portfolio company will be treated for this purpose as having been disposed of or completely written-off only to the extent that, as of the date of any such disposition or write-off, the aggregate value of all remaining investments (other than bridge financings) in such portfolio company is less than the aggregate investment contributions with respect to all existing and former investments in such portfolio company. In certain BVP funds, the post-Stepdown Date management fee base will include capitalized transaction-specific fees and expenses of unrealized investments, including certain fees (such as Investment-Related Fees (as defined below)) and expenses paid to Service Providers (as defined below), operating partners (including members of the Operating Partner Group (as defined below)), BVP or its affiliates. Further, management fees generally will not be reimbursed or refunded under the Governing Documents in the event of realizations, dispositions or partial write-downs or write- offs that occur partway through the relevant calculation period. Other Fees and Expenses The Funds typically pay organizational costs and expenses incurred by each General Partner (or ... |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure] |
|---|
Item 7. Types of Clients BVP provides investment advisory services to the Funds. Investment advice is provided directly to the Funds and not individually to the investors in the Fund. Investors in the Funds are generally “qualified purchasers” or “knowledgeable employees” as defined in the 1940 Act and “accredited investors” as defined in Regulation D promulgated under the Securities Act, and generally include, among others, high net worth individuals, banks, thrift institutions, pension and profit-sharing plans, trusts, estates, charitable organizations, university endowments, corporations, sovereign wealth funds, limited partnerships and limited liability companies. In some cases private equity professionals from other private equity firms and other service professionals (e.g., outside counsel) may also be invested in the Funds. Additionally, principals, personnel, and consultants of BVP have the ability to invest in other private equity investment vehicles (including single investor co- investments) managed by other investment advisers. In some cases, the Funds are permitted to invest in companies that are owned by such other investment vehicles, which has the potential to directly or indirectly benefit principals, personnel, or consultants of BVP. The Funds do not have a minimum size, but minimum investment commitments are generally established for investors in the Funds. The General Partner, as applicable, of each Fund is generally permitted to, in its sole discretion, permit investments below the minimum amounts set forth in the Governing Documents of such Fund. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Servicetitan Inc | 0.3 | ||
| Stubhub Holdings Inc | 0.1 | ||
| Hinge Health Inc | 0.1 | ||
| CS Disco Inc | 0.0 | ||
| Kymera Therapeutics Inc | 0.0 | ||
| Navsight Holdings Inc | 0.0 | ||
| Fiverr International Ltd | 0.0 | ||
| Fractyl Health Inc | 0.0 | ||
| TScan Therapeutics Inc | 0.0 | ||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Bessemer Venture Partners an I LP | 2026-03-30 | 83.3 M | |
| VC | Bessemer Venture Partners India II Institutional LP | [2026-03-30] | 291.8 M | |
| Filed 2025-03-04 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Bessemer Venture Partners India II LP | 2026-03-30 | 61.3 M | |
| PE | Gator Co-Invest BE LP | [2026-03-30] | 45.2 M | |
| Filed 2025-07-11 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Gator Co-Invest Li LP | [2026-03-30] | 70.9 M | |
| Filed 2025-10-17 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Gator Co-Invest TE LP | [2026-03-30] | 42.5 M | 42.7 M |
| Filed 2025-07-14 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Gator Co-Invest VE LP | [2026-03-30] | 53.8 M | |
| Filed 2025-06-06 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Gator Co-Invest PA LP | [2024-03-29] | 32.1 M | |
| Filed 2023-08-01 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Bessemer Venture Partners XII Advisors & Influencers LP | [2023-03-31] | 48.4 M | |
| Filed 2022-06-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Bessemer Venture Partners XII Institutional LP | [2023-03-31] | 3,238.4 M | |
| Filed 2022-06-27 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($B) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 36 | 20.2 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 36 | 20.2 |
| By Discretionary | ||
| Discretionary | 36 | 20.2 |
| Non-Discretionary | 0 | 0.0 |
| Total | 36 | 20.2 |
| By Non-United States Persons | ||
| Non-United States Persons | 18.5 | |
| United States Persons | 1.7 | |
| Total | 36 | 20.2 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Adam Fisher | Director | 42 | 7 | |
| Robert Goodman | Director, Executive Officer | 95 | 4 | |
| David Cowan | Director | 55 | 3 | |
| Brian Feinstein | Director, Executive Officer | 38 | 3 | |
| Robert Stavis | Director | 24 | 3 | |
| Ethan Kurzweil | Director | 23 | 3 | |
| Richard Bennett | Director | 20 | 3 | |
| Byron Deeter | Director | 71 | 2 | |
| Jeremy Levine | Director, Executive Officer | 64 | 2 | |
| Stephen Kraus | Director | 45 | 2 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001494127] | |
| 3 | [0001494127] | |
| 4 | [0001494127] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Private Equity |
| Related People Network |
|---|
| 31 people file Form D offerings alongside this firm's people. |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Tempest Therapeutics Inc OVAS
Stock Option (right to buy) · derivative
|
2014-06-13 | Grant | 6,500 | $0.00 | |
|
Tempest Therapeutics Inc OVAS
Stock Option (right to buy) · derivative
|
2013-06-07 | Grant | 4,448 | $0.00 | |
|
Eloqua Inc ELOQ
Common Stock
|
2013-02-08 | Disposed to issuer | 5,163,934 | ||
|
Tempest Therapeutics Inc NONE
Common Stock
|
2012-08-13 | Conversion | 909,090 | $0.00 | |
|
Tempest Therapeutics Inc NONE
Series A Preferred Stock · derivative
|
2012-08-13 | Conversion | 3,000,000 | $0.00 | |
|
Tempest Therapeutics Inc NONE
Series B Preferred Stock · derivative
|
2012-08-13 | Conversion | 909,090 | $0.00 | |
|
Tempest Therapeutics Inc NONE
Common Stock
|
2012-08-13 | Conversion | 1,482,944 | $0.00 | |
|
Eloqua Inc ELOQ
Series C Preferred Stock · derivative
|
2012-08-07 | Conversion | 5,163,934 | $0.00 | |
|
Eloqua Inc ELOQ
Common Stock
|
2012-08-07 | Conversion | 5,163,934 | ||
|
Verastem Inc VSTM
Stock Option (Right to Buy) · derivative
|
2012-03-06 | Grant | 12,500 | $0.00 | |
|
Verastem Inc VSTM
Series C Preferred Stock · derivative
|
2012-02-01 | Conversion | 133,333 | $0.00 | |
|
Verastem Inc VSTM
Series A Preferred Stock · derivative
|
2012-02-01 | Conversion | 4,000,000 | $0.00 | |
|
Verastem Inc VSTM
Common Stock
|
2012-02-01 | Conversion | 714,285 | $0.00 | |
|
Verastem Inc VSTM
Common Stock
|
2012-02-01 | Buy | 100,000 | $10.00 | 1,000,000 |
|
Verastem Inc VSTM
Common Stock
|
2012-02-01 | Conversion | 38,095 | $0.00 | |
|
Verastem Inc VSTM
Common Stock
|
2012-02-01 | Conversion | 1,142,857 | $0.00 | |
|
Verastem Inc VSTM
Series B Preferred Stock · derivative
|
2012-02-01 | Conversion | 2,500,000 | $0.00 |
| Comparable Firms | State | AUM |
|---|---|---|
|
THL Managers VII LLC
✚
|
MA | 21.48 B |
|
Charlesbank Capital Partners LLC
✚
|
MA | 21.06 B |
|
Madison Dearborn Partners LLC
✚
|
IL | 20.74 B |
|
Harvest Partners LP
✚
|
NY | 20.25 B |
|
Rokos Capital Management US LP
✚
|
NY | 20.20 B |
|
Audax Management Company LLC
✚
|
MA | 20.12 B |
|
Royalty Pharma Sub-Manager LLC
✚
|
NY | 19.64 B |
|
KPS Capital Partners LP
✚
|
NY | 19.08 B |
|
Great Hill Partners LP
✚
|
MA | 18.99 B |
|
Alpine Management Services III LLC
✚
|
CA | 18.91 B |